TMOD-25. GLIOBLASTOMA ORGANOIDS: A MODEL SYSTEM FOR PATIENT-SPECIFIC THERAPEUTIC TESTING

Glioblastoma treatment options remain limited due to its aggressive and invasive nature. It is increasingly appreciated that molecular heterogeneity between tumors and within tumors likely contributes to the lack of therapeutic advances. To maintain the inherent heterogeneity of glioblastoma, we emp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Salinas, Ryan, Zhang, Daniel, Jacob, Fadi, Nguyen, Phuong, Sheikh, Saad, Prokop, Stefan, Dorsey, Jay, Nasrallah, MacLean, Brem, Steven, O’Rourke, Donald, Ming, Guo-li, Song, Hongjun
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Tumor Models
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846667/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1124
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars